Asia-Pacific Cardiovascular Devices Market – Share, Outlook, Trends, Size and Forecast (2024 – 2032)

Published : 30 Aug 2024
Report Type : Regional

Share This On

Home > Reports > Medical Devices > Healthcare > Asia-Pacific Cardiovascular Devices Market – Share, Outlook, Trends, Size and Forecast (2024 – 2032)
Asia-Pacific Cardiovascular Devices Market - Size
Study Period
2018 - 2030
Base Year For Estimation
2023
Forecast Data Period
2024-2030
Historical Data Period
2018-2021
CAGR
7 %
Source: Envision Intelligence Analysis & Experts Insights.
*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

CVD (Cardiovascular Disease) is a disease that involves the heart and blood vessels. High blood pressure, smoking, diabetes, heart failure, heart arrhythmia, and others are the major reasons for CVD. To overcome all these problems, Cardiovascular Devices are implemented to treat CVD and to monitor the performance and functioning of the cardiovascular system. They are many types of cardiovascular devices, which are used for the monitoring, pressurising, treatment, measurement, and therapies.

Asia Pacific Cardiovascular Devices Market Segments Size & Growth:

Asia Pacific Cardiovascular devices market is projected to reach approximately USD XX Billion by 2024, at a CAGR of XX% from XX Billion in 2017 during the forecast period. The key attributes promoting the cardiovascular devices market growth are growing geriatric population, high preference of minimally invasive procedures, and rising prevalence of cardiovascular disease. Technical innovations and advancements in the cardiovascular devices have made a major impact on the Asia Pacific cardiovascular devices market. Cardiovascular disease is the major cause of all the deaths. To reduce the time to hemostasis, to enable early ambulation, and to improve patient comfort these medical devices are implemented. Cardiac monitoring refers to the continuous monitoring of the heart activity and has to make an assessment relative to the patient’s cardiac rhythm. It generally includes electrocardiography. By considering the reports of World Health Organization 19 Million people across the globe are died in 2012, due to CVD (Cardiovascular Disease), and around 21 Million people are estimated to die by 2024. In India, nearly 32 million people have cardiac problems. The market analysis spread over India, China, South-Korea, Japan and Australia in Asia Pacific region. These emerging economies are exhibiting

Asia-Pacific Cardiovascular Devices Market - Growth
Source: Envision Intelligence Analysis & Experts Insights.
*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
a strong potential accounted with the developing healthcare infrastructure, and others. Growing prevalence of cardiovascular diseases, augmenting geriatric population, and obese population is also the factors contributing to the cardiovascular diagnostic and monitoring devices market, which holds the largest market share across the globe. Historically, the FDA and doctors have recommended that pacemaker patients should not undergo an MRI (Magnetic Resource Imaging). Traditional pacemakers are not compatible with MRI, due to the harmful interaction between the device and the electromagnetic field.

Asia Pacific Cardiovascular Devices Market Segments Share:

Asia Pacific Cardiovascular Devices Market is segmented by product type which comprises of Cardiac Rhythm Management (CRM), Cardiac Monitoring Devices, Cardiac Surgery Devices, interventional cardiology, peripheral vascular devices, plaque modification devices, and flow alteration devices. External defibrillators can be used as emergency life-saving, with the advent of the sudden heart attack. Rising incidence of sudden heart attacks is propelling the market growth for CRM devices in the United States. Due to saturation of pacemakers implementation will witness a slight decline in the overall CRM devices market share. By procedure, the market is segmented into minimally invasive heart surgery, open heart surgery, heart valve repair or replacement, and angioplasty. By technology, the market is further classified into cardiopulmonary bypass products, bioresorbable stents, and cardiac assist devices. By end-users and applications, the market is further divided into segments. By application cardiac arrhythmia held the highest market share owing to the high prevalence of cardiac arrhythmia. By Geography, Asia Pacific region is witnessed as the fastest growing region in cardiovascular devices market, owing to the rise in awareness level, and growing geriatric population. Growing rate of heart diseases

You can also purchase parts of this report. Do you want to check out a section wise price list

Asia-Pacific Cardiovascular Devices Market - Porter's Five Force Analysis
Source: Envision Intelligence Analysis & Experts Insights.
*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
in emerging countries like India and China are promoting the cardiovascular devices market during the forecast period.

Asia Pacific Cardiovascular Devices Market Trends:

  • Medtronic Company the top player in the cardiovascular devices market has launched bio trend oxygenation saturation and hematocrit monitor to provide the real-time information of the patient’s blood values to respond immediately.
  • Medtronic, the player in the cardiovascular devices market, has launched Trailblazer support catheters to access and track through the vessel, to enable guidewire exchanges and to contrast during the endovascular procedures.

Asia Pacific Cardiovascular Devices Market Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Europe Diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with major competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

The major key players in the Asia Pacific Cardiovascular Devices Market are:

 

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Arrow International, Inc.
  • Jude Medical
  • Medtronic
  • GE Healthcare
  • SIEMENS Healthcare

Along with these companies, there were many other companies considered/cited in the report while analysing the Asia-Pacific Cardiovascular Devices market. These companies hold substantial share-owning to the nature of the industry whereas rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and strong customer base.

 

 

 

Exclusive Benefits

Credibility and
Transparency

We actively recruit consumers, business professionals, and elusive individuals for our research panels, fostering enduring relationships. Our commitment to transparency is evident in the comprehensive listing of primary and secondary data sources, ensuring unwavering credibility in our reports.

Exhaustive
Coverage

Uncover the full spectrum with Envision Intelligence. Our detailed and extensive geographical coverage, coupled with survey consultation services, spans brand tracking, concept testing, and consumer behaviour analysis. Adapt to your evolving needs with scalable market research services that leave no facet unexplored.

Competitive
Edge

Stay ahead with Envision Intelligence. Our reports provide the latest market updates up to the date of purchase. Recognising the urgency of impactful decisions, we deliver timely analyses on the unprecedented choices made by CXOs during the COVID-19 crisis—providing valuable insights at no extra cost.

Golden
pportunities

Unearth hidden gems with Envision Intelligence. Our analysts and consultants conduct a comprehensive strategic sieve analysis, augmented by AI tools, to identify non-obvious, golden, and emerging opportunities. Evaluate possibilities that set you apart in the market.

Top-notch Reportsd
Guaranteed

Experience unparalleled depth with Envision Intelligence. Over 70% of our research is exclusive, establishing us as the premier source for in-depth and extensive market insights. Elevate your decision-making with reports that go beyond the ordinary.

Post Purchase
Support

Empower your journey with Envision Intelligence. Our commitment extends beyond the purchase. Enjoy post-purchase support for three months, with queries addressed within 24 business hours via telephone or email. We stand by you in your quest for ongoing success.

Other Reports

Global Sesame Seeds Market – Size, Outlook, Trends and...

Starting from $2700

Global Meat Ingredients Market – Growth, Trends And...

Starting from $2700

Unmanned Aerial Vehicle Drones Market – Size, Outlook,...

Starting from $2700

Stay in the loop

Keep up-to-date with our weekly newsletter, Media Pulse.

Data-driven market insights & solutions

Follow Us On

We Accept

Our Office

30 N Gould St Ste N Sheridan,
WY 82801

© 2024 - Envision Intelligence | All Rights Reserved.
Designed by Webixion